Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | KIF11 | P52732 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Mandelic Acid SCHEMBL8757198 | 0.87 | LMNA (0.62) | LMNAMAPK1MAPTKMT2ACYP2D6 | |
| Mandelic Acid SCHEMBL4326804 | 0.85 | LMNA (0.60) | LMNAMAPK1MAPTKMT2ACYP2D6 | |
| Atrolactamide SCHEMBL78236 | 0.84 | MAPT (0.65) | LMNAMAPTKMT2ACYP2D6CYP1A2 | |
| Mandelic Acid SCHEMBL1275427 | 0.78 | LMNA (0.86) | LMNAMAPK1CYP2D6HPGDCES2 | |
| Mandelic Acid SCHEMBL11083521 | 0.78 | LMNA (0.86) | LMNAMAPK1KMT2ACYP2D6HPGD | |
| SCHEMBL7563030 | 0.78 | LMNA (0.50) | LMNAMAPK1KMT2ACYP2D6HPGD | |
| Atrolactamide SCHEMBL28842804 | 0.78 | MAPT (0.57) | LMNAMAPTKMT2ACYP2D6CYP1A2 | |
| Mandelic Acid SCHEMBL8876737 | 0.76 | LMNA (0.90) | LMNAMAPK1KMT2ACYP2D6HPGD | |
| Mandelic Acid SCHEMBL6056301 | 0.76 | LMNA (0.90) | LMNAMAPK1KMT2ACYP2D6HPGD | |
| Mandelic Acid SCHEMBL7279536 | 0.76 | LMNA (0.90) | LMNAMAPK1KMT2ACYP2D6HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260008766-A1 | EPISULFIDE COMPOUND AND OPTICAL MATERIAL COMPOSITION THEREOF | Efirm New Material Co., Ltd. (CN) | 2026-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260008766-A1 | EPISULFIDE COMPOUND AND OPTICAL MATERIAL COMPOSITION THEREOF | LATS1, LATS2, TST | LMNA 4519/4885MAPK1 619/4885MAPT 911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.